Partnered with J. Craig Venter on the launch of Diploid Genomics as sole external investor in the seed round.
Diploid Genomics, Inc
Diploid Genomics, Inc. (DGI) is building a new foundation for precision health—uniting phased diploid genome sequencing with multimodal clinical data and advanced AI to help detect disease earlier, predict risk more accurately, and guide more personalized care.